West Pharmaceutical Services | WST - Gross Profit On Sales



West Pharmaceutical Services reported $273.9M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Align Technology USD 708.12M 28.01M Jun/2025
Avanos Medical USD 92.1M 2.3M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Cooper Companies USD 692M 12.9M Jul/2025
Dentsply International USD 490M 24M Jun/2025
Haemonetics USD 192.24M 806K Jun/2025
ICU Medical USD 208.06M 2.04M Jun/2025
Insulet USD 452.2M 43.2M Jun/2025
Integra LifeSciences USD 209.33M 5.81M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
J&J USD 14.6B 816M Mar/2025
Medtronic USD 5.12B 695M Jul/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Neogen USD 92.85M 17.41M May/2025
Quidel USD 227M 116.3M Jun/2025
Repligen USD 91.14M 385K Jun/2025
Solventum Corp 1.18B 51M Jun/2025
STAAR Surgical USD 32.8M 4.79M Jun/2025
Terumo JPY 145.47B 6.94B Jun/2025
West Pharmaceutical Services USD 273.9M 42M Jun/2025